Orange Book product · Generic (ANDA)
PEMETREXED DISODIUM
PEMETREXED DISODIUM
At a glance
Dec 11, 2023
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 11, 2023
2 yr 7 mo ago
Today
Pharmaceutical detail
Active ingredient
PEMETREXED DISODIUM
Strength
EQ 100MG BASE/VIAL
Dosage form
POWDER
Route
INTRAVENOUS
TE code
AP
Application
ANDA 216582
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of PEMETREXED DISODIUM
- 2023PEMETREXEDBrand (NDA)
NDA 215179 · SHILPA
- 2022PEMETREXED DISODIUMBrand (NDA)
NDA 214408 · ACCORD HLTHCARE
- 2022PEMETREXED DISODIUMBrand (NDA)
NDA 214218 · HOSPIRA
- 2022PEMETREXED DISODIUMBrand (NDA)
NDA 214657 · SANDOZ
- 2007ALIMTABrand (NDA)
NDA 021462 · LILLY
- 2024PEMETREXED DISODIUMGeneric (ANDA)
ANDA 215460 · HETERO LABS LTD VI
- 2023PEMETREXED DISODIUMGeneric (ANDA)
ANDA 210047 · AMNEAL
- 2023PEMETREXED DISODIUMGeneric (ANDA)
ANDA 203628 · PHARMOBEDIENT
- 2022PEMETREXED DISODIUMGeneric (ANDA)
ANDA 215479 · MEITHEAL
- 2022PEMETREXED DISODIUMGeneric (ANDA)
ANDA 214436 · BAXTER HLTHCARE CORP
- 2022PEMETREXED DISODIUMGeneric (ANDA)
ANDA 203485 · ACCORD HLTHCARE
- 2022PEMETREXED DISODIUMGeneric (ANDA)
ANDA 209085 · APOTEX
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
